Skip to main content
Erschienen in: Urolithiasis 3/2005

01.06.2005 | Original Paper

Filling cystoureterography facilitates stone visualization in patients with previously inserted double-J ureteral stents

verfasst von: Sergey George Kravchick, Dmitry Shumalinsky, Michael Jeshurun-Koren, Eugen Stepnov, Shmuel Cytron

Erschienen in: Urolithiasis | Ausgabe 3/2005

Einloggen, um Zugang zu erhalten

Abstract

In our study, we assessed the ability of a filling cystogram to induce vesicoureteral reflux (VUR) and to evaluate its role in stone targeting during ESWL in the presence of a double-J ureteral stent (JJ-S). Filling cystoureterography was performed during ESWL in 17 patients with previously inserted 4.7 F JJ-S. The examination ended with stone localization. In every procedure, 3,500 shock waves were delivered with an energy range of 18–23 kV. Patients were evaluated 4 weeks after ESWL. A stone-free result was defined as no evidence of calculi in the first or second visits. Because contrast material was employed in this study, we also evaluated its possible interference with the results of lithotripsy. All radiolucent or poorly calcified stones were successfully localized. In four patients, rhythmic suprapubic manual pressure was performed to initiate VUR. Reflux was low grade in 35% and high grade in 65% of renal units. The efficiency quotient reached 59%. In vitro artificial stones were successfully disintegrated both in water and solutions of Ultravist. In the presence of a JJ-S, filling cystography can easily localize radiolucent stones during SWL. No special catheters or stents are required for this technique. Ultravist in particular does not affect the results of ESWL unfavorably.
Literatur
1.
Zurück zum Zitat Mosli HA, Farsi HM, al-Zimaity MF, Saleh TR, Al-Zamzami MM (1991) Vesicoureteral reflux in patients with double pigtail stents. J Urol 146: 966PubMed Mosli HA, Farsi HM, al-Zimaity MF, Saleh TR, Al-Zamzami MM (1991) Vesicoureteral reflux in patients with double pigtail stents. J Urol 146: 966PubMed
2.
Zurück zum Zitat Fine H, Gordon RL, Lebensart PD (1989) Extracorporeal shock wave lithotripsy and stents: fluoroscopic observations and a hypothesis on the mechanisms of stent function. Urol Radiol 11: 37PubMed Fine H, Gordon RL, Lebensart PD (1989) Extracorporeal shock wave lithotripsy and stents: fluoroscopic observations and a hypothesis on the mechanisms of stent function. Urol Radiol 11: 37PubMed
3.
Zurück zum Zitat Sundaram CP, Saltzman B (1998) An effective technique to facilitate radiographic stone visualization with an internal stent during shock wave lithotripsy. J Urol 160: 1414PubMed Sundaram CP, Saltzman B (1998) An effective technique to facilitate radiographic stone visualization with an internal stent during shock wave lithotripsy. J Urol 160: 1414PubMed
4.
Zurück zum Zitat Gross LJ, Brannen GE (1990) Injectable ureteral stent. Urology 35: 263PubMed Gross LJ, Brannen GE (1990) Injectable ureteral stent. Urology 35: 263PubMed
5.
Zurück zum Zitat Cimentepe E, Unsal A, Saglam R, Balbay MD (2003) Comparison of the clinical outcome of extracorporeal shockwave lithotripsy in patients with radiopaque v radiolucent ureteral calculi. J Endourol 17: 863PubMed Cimentepe E, Unsal A, Saglam R, Balbay MD (2003) Comparison of the clinical outcome of extracorporeal shockwave lithotripsy in patients with radiopaque v radiolucent ureteral calculi. J Endourol 17: 863PubMed
6.
Zurück zum Zitat Buchholz NPN, Van Rossum M (2001) The radiolucent ureteric calculus at the end of a contrast-medium column: where to focus the shock waves. BJU Int 88: 325PubMed Buchholz NPN, Van Rossum M (2001) The radiolucent ureteric calculus at the end of a contrast-medium column: where to focus the shock waves. BJU Int 88: 325PubMed
7.
Zurück zum Zitat Pearle MS, McClennan BL, Roehrborn CG, Clayman RV (1997) Bolus injection v drip infusion contrast administration for ureteral stone targeting during shockwave lithotripsy. J Endourol 11: 163PubMed Pearle MS, McClennan BL, Roehrborn CG, Clayman RV (1997) Bolus injection v drip infusion contrast administration for ureteral stone targeting during shockwave lithotripsy. J Endourol 11: 163PubMed
8.
Zurück zum Zitat Joshi HB, Obadeyi OO, Rao PN (1999) A comparative analysis of nephrostomy, JJ stent and urgent in situ extracorporeal shock wave lithotripsy for obstructing ureteric stones. Br J Urol 84: 264 Joshi HB, Obadeyi OO, Rao PN (1999) A comparative analysis of nephrostomy, JJ stent and urgent in situ extracorporeal shock wave lithotripsy for obstructing ureteric stones. Br J Urol 84: 264
9.
Zurück zum Zitat Tligui M, Khadime M.R.El., Tchala K, Haab F, Traxer O, Gattegno B, Thibault P (2003) Emergency extracorporeal shock wave lithotripsy (ESWL) for obstructing ureteral stones. Eur Urol 43: 552PubMed Tligui M, Khadime M.R.El., Tchala K, Haab F, Traxer O, Gattegno B, Thibault P (2003) Emergency extracorporeal shock wave lithotripsy (ESWL) for obstructing ureteral stones. Eur Urol 43: 552PubMed
10.
Zurück zum Zitat Buchholz NPN, Van Rossum M (2001) Shock wave lithotripsy treatment of radiolucent ureteric calculi with the help of contrast medium. Eur Urol 39: 200PubMed Buchholz NPN, Van Rossum M (2001) Shock wave lithotripsy treatment of radiolucent ureteric calculi with the help of contrast medium. Eur Urol 39: 200PubMed
Metadaten
Titel
Filling cystoureterography facilitates stone visualization in patients with previously inserted double-J ureteral stents
verfasst von
Sergey George Kravchick
Dmitry Shumalinsky
Michael Jeshurun-Koren
Eugen Stepnov
Shmuel Cytron
Publikationsdatum
01.06.2005
Verlag
Springer-Verlag
Erschienen in
Urolithiasis / Ausgabe 3/2005
Print ISSN: 2194-7228
Elektronische ISSN: 2194-7236
DOI
https://doi.org/10.1007/s00240-004-0449-z

Weitere Artikel der Ausgabe 3/2005

Urolithiasis 3/2005 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

Stufenschema weist Prostatakarzinom zuverlässig nach

22.04.2024 Prostatakarzinom Nachrichten

Erst PSA-Test, dann Kallikrein-Score, schließlich MRT und Biopsie – ein vierstufiges Screening-Schema kann die Zahl der unnötigen Prostatabiopsien erheblich reduzieren: Die Hälfte der Männer, die in einer finnischen Studie eine Biopsie benötigten, hatte einen hochgradigen Tumor.

Harnwegsinfektprophylaxe: Es geht auch ohne Antibiotika

20.04.2024 EAU 2024 Kongressbericht

Beim chronischen Harnwegsinfekt bei Frauen wird bisher meist eine Antibiotikaprophylaxe eingesetzt. Angesichts der zunehmenden Antibiotikaresistenz erweist sich das Antiseptikum Methenamin-Hippurat als vielversprechende Alternative, so die Auswertung einer randomisierten kontrollierten Studie.

Update Urologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.